Author at Microdose

Eric Greenbaum

Eric Greenbaum is a scientist and inventor, deeply passionate about improving mental health. For most of the last 10 years Eric was the chief science officer for Vireo Health, a multistate medical cannabis company where he founded and led their R&D team creating more than 70 unique products, filing more than 25 patent applications, and publishing original research in leading scientific journals. Eric is also the founder of NYVR - the largest networking group for virtual reality developers and enthusiasts on the east coast. Eric has a degree in neuroscience from Emory University, a Masters’ degree in pharmacology from UPENN, and a law degree from St. John’s University.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Health & Wellness

9 Jun 2023

Can Virtual Reality Reduce Costs, Improve Scalability and Access to Psychedelics?

Extended or Virtual Reality platforms deliver psychological support to reduce the burden on therapists, reduce costs, and provide improved patient access...

By Eric Greenbaum

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts

10 Oct 2025

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

In the wake of Gilgamesh’s billion-dollar exit, a new wave of companies is emerging, smaller, stealthier, and far more scientifically disciplined than their first-wave predecessors. Their mission: harness the therapeutic...

By Madison Roberts

Eric Greenbaum is a scientist and inventor, deeply passionate about improving mental health. For most of the last 10 years Eric was the chief science officer for Vireo Health, a multistate medical cannabis company where he founded and led their R&D team creating more than 70 unique products, filing more than 25 patent applications, and publishing original research in leading scientific journals. Eric is also the founder of NYVR - the largest networking group for virtual reality developers and enthusiasts on the east coast. Eric has a degree in neuroscience from Emory University, a Masters’ degree in pharmacology from UPENN, and a law degree from St. John’s University.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads